These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 16414077)
1. Antimyoclonic effect of levetiracetam in MERRF syndrome. Mancuso M; Galli R; Pizzanelli C; Filosto M; Siciliano G; Murri L J Neurol Sci; 2006 Apr; 243(1-2):97-9. PubMed ID: 16414077 [TBL] [Abstract][Full Text] [Related]
2. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Magaudda A; Gelisse P; Genton P Epilepsia; 2004 Jun; 45(6):678-81. PubMed ID: 15144434 [TBL] [Abstract][Full Text] [Related]
3. Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients. Crest C; Dupont S; Leguern E; Adam C; Baulac M Neurology; 2004 Feb; 62(4):640-3. PubMed ID: 14981187 [TBL] [Abstract][Full Text] [Related]
4. MERRF syndrome without ragged-red fibers: the need for molecular diagnosis. Mancuso M; Petrozzi L; Filosto M; Nesti C; Rocchi A; Choub A; Pistolesi S; Massetani R; Fontanini G; Siciliano G Biochem Biophys Res Commun; 2007 Mar; 354(4):1058-60. PubMed ID: 17275787 [TBL] [Abstract][Full Text] [Related]
5. Limited efficacy of levetiracetam on myoclonus of different etiologies. Lim LL; Ahmed A Parkinsonism Relat Disord; 2005 Mar; 11(2):135-7. PubMed ID: 15734675 [TBL] [Abstract][Full Text] [Related]
6. Antimyoclonic Effect of Levetiracetam and Clonazepam Combined Treatment on Myoclonic Epilepsy with Ragged-Red Fiber Syndrome with m.8344A>G Mutation. Su LJ; Wang YL; Han T; Qiao S; Zang KJ; Wu HK; Su YX; Liu LL; Liu XW Chin Med J (Engl); 2018 Oct; 131(20):2433-2438. PubMed ID: 30334528 [TBL] [Abstract][Full Text] [Related]
7. The expanding mutational spectrum of MERRF substitution G8361A in the mitochondrial tRNALys gene. Rossmanith W; Raffelsberger T; Roka J; Kornek B; Feucht M; Bittner RE Ann Neurol; 2003 Dec; 54(6):820-3. PubMed ID: 14681892 [TBL] [Abstract][Full Text] [Related]
8. Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam. Kobayashi K; Takeuchi A; Oka M; Akiyama M; Ohtsuka Y Brain Dev; 2012 May; 34(5):368-71. PubMed ID: 21889282 [TBL] [Abstract][Full Text] [Related]
17. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus. Gibbs JE; Walker MC; Cock HR Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome. García C; Rubio G Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296 [TBL] [Abstract][Full Text] [Related]